Tailor-Made stent grafts take on tough aneurysms
NCT ID NCT07065760
First seen May 20, 2026
Summary
This study tests a physician-modified endovascular graft (PMEG) to repair juxtarenal aortic aneurysms—bulges in the aorta near the kidneys. Fifteen participants will receive the custom graft via a minimally invasive procedure and be followed for up to 5 years. The goal is to see if the device is safe and works well, measuring complications like death, stroke, or kidney failure within 30 days, and success at 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JUXTARENAL ABDOMINAL AORTIC ANEURYSM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Utah Hospital
RECRUITINGSalt Lake City, Utah, 84112, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Physician-modified endovascular graft (a custom stent-graft device)
What this could lead to
If successful, this could offer a less invasive treatment option for patients with complex aortic aneurysms who may not be candidates for standard surgery.
What could go wrong
This is a very small early study (15 people) with no control group, so results may not apply widely. The procedure carries risks like bleeding, kidney failure, or stroke.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.